These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 35284267)

  • 1. Identifying
    Li J; Liu Y; Dong W; Zhou Y; Wu J; Luan K; Qi L
    Quant Imaging Med Surg; 2022 Mar; 12(3):1893-1908. PubMed ID: 35284267
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of a rank-based radiomic signature with individualized prognostic value for lung adenocarcinoma in a multi-cohort study.
    Liu Y; Wang Z; Yang L; Zhang M; Li M; Zhang J; Tang L; Jiang Z; Li X; Deng J; Meng Q; Liu S; Wang K; Qi L
    Eur J Radiol; 2024 Oct; 181():111782. PubMed ID: 39427495
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development and validation of a robust immune-related prognostic signature in early-stage lung adenocarcinoma.
    Wu P; Zheng Y; Wang Y; Wang Y; Liang N
    J Transl Med; 2020 Oct; 18(1):380. PubMed ID: 33028329
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Unique Gene Signature Predicting Recurrence Free Survival in Stage IA Lung Adenocarcinoma.
    Carr SR; Wang H; Hudlikar R; Lu X; Zhang MR; Hoang CD; Yan F; Schrump DS
    J Thorac Cardiovasc Surg; 2023 Apr; 165(4):1554-1564. PubMed ID: 37608989
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radiomic signature of
    Jiang Y; Yuan Q; Lv W; Xi S; Huang W; Sun Z; Chen H; Zhao L; Liu W; Hu Y; Lu L; Ma J; Li T; Yu J; Wang Q; Li G
    Theranostics; 2018; 8(21):5915-5928. PubMed ID: 30613271
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Construction and validation of a novel prognostic signature of microRNAs in lung adenocarcinoma.
    Li W; Liu S; Su S; Chen Y; Sun G
    PeerJ; 2021; 9():e10470. PubMed ID: 33510968
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Establishment and validation of a prognostic signature for lung adenocarcinoma based on metabolism-related genes.
    Wang Z; Embaye KS; Yang Q; Qin L; Zhang C; Liu L; Zhan X; Zhang F; Wang X; Qin S
    Cancer Cell Int; 2021 Apr; 21(1):219. PubMed ID: 33858449
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of a methylomics-associated nomogram for predicting overall survival of stage I-II lung adenocarcinoma.
    Wang H; Wei C; Pan P; Yuan F; Cheng J
    Sci Rep; 2021 May; 11(1):9938. PubMed ID: 33976305
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CT-derived radiomic analysis for predicting the survival rate of patients with non-small cell lung cancer receiving radiotherapy.
    Zhang N; Zhang X; Li J; Ren J; Li L; Dong W; Liu Y
    Phys Med; 2023 Mar; 107():102546. PubMed ID: 36796178
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predicting Chemo-Radiotherapy Sensitivity With Concordant Survival Benefit in Non-Small Cell Lung Cancer
    Liu Y; Qi H; Wang C; Deng J; Tan Y; Lin L; Cui Z; Li J; Qi L
    Front Oncol; 2022; 12():832343. PubMed ID: 35814422
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of a novel gene expression signature associated with overall survival in patients with lung adenocarcinoma: A comprehensive analysis based on TCGA and GEO databases.
    Zhao J; Guo C; Ma Z; Liu H; Yang C; Li S
    Lung Cancer; 2020 Nov; 149():90-96. PubMed ID: 33002836
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Non-invasive Radiomic Method Using
    Li L; Mu W; Wang Y; Liu Z; Liu Z; Wang Y; Ma W; Kong Z; Wang S; Zhou X; Wei W; Cheng X; Lin Y; Tian J
    Front Oncol; 2019; 9():1183. PubMed ID: 31803608
    [No Abstract]   [Full Text] [Related]  

  • 13. Application of a Machine Learning Approach for the Analysis of Clinical and Radiomic Features of Pretreatment [
    Nakajo M; Jinguji M; Tani A; Kikuno H; Hirahara D; Togami S; Kobayashi H; Yoshiura T
    Mol Imaging Biol; 2021 Oct; 23(5):756-765. PubMed ID: 33763816
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comprehensive Analysis of Immune Implication and Prognostic Value of
    Zeng Y; Zhang Z; Chen H; Fan J; Yuan W; Li J; Zhou S; Liu W
    Front Oncol; 2021; 11():798425. PubMed ID: 35047409
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A seven-gene prognostic signature predicts overall survival of patients with lung adenocarcinoma (LUAD).
    Al-Dherasi A; Huang QT; Liao Y; Al-Mosaib S; Hua R; Wang Y; Yu Y; Zhang Y; Zhang X; Huang C; Mousa H; Ge D; Sufiyan S; Bai W; Liu R; Shao Y; Li Y; Zhang J; Shi L; Lv D; Li Z; Liu Q
    Cancer Cell Int; 2021 Jun; 21(1):294. PubMed ID: 34092242
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential expression analysis at the individual level reveals a lncRNA prognostic signature for lung adenocarcinoma.
    Peng F; Wang R; Zhang Y; Zhao Z; Zhou W; Chang Z; Liang H; Zhao W; Qi L; Guo Z; Gu Y
    Mol Cancer; 2017 Jun; 16(1):98. PubMed ID: 28587642
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A methylation-based nomogram for predicting survival in patients with lung adenocarcinoma.
    Wang X; Zhou B; Xia Y; Zuo J; Liu Y; Bi X; Luo X; Zhang C
    BMC Cancer; 2021 Jul; 21(1):801. PubMed ID: 34247575
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Angiogenesis-related lncRNAs predict the prognosis signature of stomach adenocarcinoma.
    Han C; Zhang C; Wang H; Li K; Zhao L
    BMC Cancer; 2021 Dec; 21(1):1312. PubMed ID: 34876056
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Unique metastasis-associated lncRNA signature optimizes prediction of tumor relapse in lung adenocarcinoma.
    Zhang X; Han J; Du L; Li X; Hao J; Wang L; Zheng G; Duan W; Xie Y; Zhao Y; Zhang X; Zou M; Wang C
    Thorac Cancer; 2020 Mar; 11(3):728-737. PubMed ID: 31994347
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic significance of standardized uptake value on preoperative ¹⁸F-FDG PET/CT in patients with ampullary adenocarcinoma.
    Choi HJ; Kang CM; Jo K; Lee WJ; Lee JH; Ryu YH; Lee JD
    Eur J Nucl Med Mol Imaging; 2015 May; 42(6):841-7. PubMed ID: 25216749
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.